Heiko Enderling

Heiko Enderling is a German-American mathematical biologist and mathematical oncologist known for his work in quantitative personalized oncology. He is Professor in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center, where he directs the Computational Modeling in Radiation Oncology Program and co-leads the Computational Modeling for Precision Medicine focus within the Institute for Data Science in Oncology. His research integrates mathematical modeling, systems biology, and clinical data to create predictive tools and digital twins for cancer therapy.

He is a Senior Member in the Department of Integrated Mathematical Oncology at Moffitt Cancer Center, editor of the Bulletin of Mathematical Biology, and president of the Society for Mathematical Biology (2021–2023).

Education and early career Enderling studied computervisualistik, a discipline that combines computer science, visualization, and medicine, at Otto-von-Guericke University Magdeburg in Germany, where he earned his Diplom-Ingenieur degree in 2003.

He pursued doctoral studies at the University of Dundee in Scotland, completing a Ph.D. in Mathematical Biology in 2006 under the supervision of Mark Chaplain, Glenn Rowe, and Alexander Anderson.

His dissertation, Mathematical modelling of breast tumour development, treatment and recurrence, explored computational methods for simulating tumor growth and recurrence following therapy, especially external beam radiotherapy and targeted intraoperative radiotherapy (Targit).

After his doctorate, Enderling conducted postdoctoral research at Tufts University's Center for Cancer Systems Biology at St. Elizabeth's Medical Center in Boston. In 2013, he moved to the Moffitt Cancer Center in Tampa, Florida, where he became a Senior Member in the Department of Integrated Mathematical Oncology. At Moffitt, he established the Quantitative Personalized Oncology laboratory, advancing the integration of mathematical and computational modeling into cancer research and prospective clinical trials.

In 2023, Enderling joined The University of Texas MD Anderson Cancer Center as Professor of Radiation Oncology. At MD Anderson Cancer Center, he founded and directs the Computational Modeling in Radiation Oncology Program and assumed a leadership role in the Institute for Data Science in Oncology, helping to build infrastructure for the development and clinical application of digital twin technologies.

Enderling was named a Centennial Postdoctoral Fellow of the American Association for Cancer Research in 2008, and Fellow of the Society for Mathematical Biology in 2021.

Research Enderling's work focuses on computational modeling of tumor growth, immune interactions, and therapy response with specific focus on radiation therapy. He is a leading advocate for digital twins in oncology, which are virtual patient avatars updated with real-time clinical data to predict treatment outcomes and guide adaptive therapy.

His models, inspired in part by hurricane forecasting methods, aim to reduce the "cone of uncertainty" in clinical predictions by integrating patient-specific imaging, molecular, and clinical data. He deployed approaches such as phase plane analysis to characterize nonlinear relationships between tumor and immune cells, identifying pre-treatment tumor-immune ecosystems that separate remission from recurrence.

Enderling's work has also influenced clinical practice. Collaborating with clinicians, his group contributed to trials that used mathematical modeling to inform patient-specific radiation doses that improve response for high-risk patients. More recently, he has advanced digital twin technologies that combine immunotherapy, chemotherapy, and radiation data with computational models to further personalize treatment strategies. He is known for developing most parsimonious mathematical models that can be calibrated with routinely collected clinical data to ensure identifiability and prediction accuracy.

Beyond his research, Enderling has been active in building educational programs that bridge mathematics and oncology. After joining Moffitt in 2013, he collaborated with Dartmouth mathematician Dorothy Wallace to establish a semester-long program that brings Dartmouth math majors to Moffitt to study mathematical oncology. Since 2018, students in this program have spent eight weeks combining coursework in applied mathematics with mentored research in cancer modeling, producing independent projects presented at the end of the program. At the graduate level, he co-developed and served as founding director of the University of South Florida / Moffitt Cancer Center PhD program in Integrated Mathematical Oncology.

In addition to university-level training, Enderling helped launch HIP-IMO (High School Internship Program in Integrated Mathematical Oncology), an eight-week summer program for high school juniors and seniors. HIP-IMO introduces students to cancer biology, computational modeling, and computer programming, offering early exposure to interdisciplinary research careers.

Recognition In 2008, Enderling received the American Association for Cancer Research Centennial Postdoctoral Fellowship Award, which supported his pioneering studies in cancer stem cell modeling.

Selected publications